APOE and Alzheimer disease: Due to the great significant differences in carriers of the APOE ε4 allele between AD patients (40.8%) and controls (11.3%), P = 0.0001 OR = 5.90 (3.16–11.01), a second analysis in these groups was proposed by APOE rs429358 ε4 status.